Jon Napitupulu

Taysha Gene Therapies granted a new employee an option to purchase 311,000 shares of company stock. The option, granted...

Capricor Therapeutics has submitted a Biologics License Application (BLA) to the U.S. FDA for deramiocel, a cell therapy designed...

Atavistik Bio and Pfizer have partnered to discover novel allosteric therapeutics for two undisclosed targets chosen by Pfizer. Atavistik...

Neumora Therapeutics announced Phase 3 trial results for its major depressive disorder (MDD) drug, navacaprant. The KOASTAL-1 study, the...

In a recent interview, we spoke with Kari Brown, Chief Medical Officer, and Woody Bryan, Chief Executive Officer, from...

A new report from ResearchAndMarkets.com analyzes the burgeoning cancer immunotherapy market, projecting its growth through 2029. The report examines...

Firefly Neuroscience (NASDAQ: AIFF) secured up to $12.4 million in financing, consisting of $2.4 million in convertible notes and...

SciSparc Ltd. (Nasdaq: SPRC) has renewed its approval from the Israeli Medical Cannabis Agency (IMCA) to continue its clinical...

Hutchmed is divesting its 45% stake in Shanghai Hutchison Pharmaceuticals Limited (SHPL) for approximately US$608 million to GP Health...

Verastem Oncology’s New Drug Application (NDA) for a combination therapy of avutometinib and defactinib, designed to treat recurrent low-grade...